83 related articles for article (PubMed ID: 6692369)
1. Production of a tumor cytolytic factor(s) by activated human alveolar macrophages and its action.
Sone S; Tachibana K; Ishii K; Ogawara M; Tsubura E
Cancer Res; 1984 Feb; 44(2):646-51. PubMed ID: 6692369
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.
Sone S; Lopez-Berestein G; Fidler IJ
J Natl Cancer Inst; 1985 Mar; 74(3):583-90. PubMed ID: 3856062
[TBL] [Abstract][Full Text] [Related]
3. In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin.
Sone S; Moriguchi S; Shimizu E; Ogushi F; Tsubura E
Cancer Res; 1982 Jun; 42(6):2227-31. PubMed ID: 7074604
[TBL] [Abstract][Full Text] [Related]
4. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
6. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
7. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
[TBL] [Abstract][Full Text] [Related]
8. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity to various human tumor cell lines of a tumor cytotoxic factor(s) produced by human alveolar macrophages.
Sone S; Mutsuura S; Ishii K; Shirahama T; Tsubura E
Gan; 1984 Oct; 75(10):920-8. PubMed ID: 6439593
[TBL] [Abstract][Full Text] [Related]
10. Release of tumor cytolytic/cytostatic factor(s) by in vitro cisplatin treated macrophages: enhanced tumoricidal activity by increase in osmotic fragility of target cells.
Singh SM; Sodhi A; Pai K; Geetha B
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):67-73. PubMed ID: 1804054
[TBL] [Abstract][Full Text] [Related]
11. [Activation of the production of cytotoxic factors by mouse spleen cells exposed to the combined action of lipopolysaccharide and muramyl dipeptide in vitro].
Rakhmilevich AL; Rakhimova MS
Biull Eksp Biol Med; 1988 Apr; 105(4):483-6. PubMed ID: 3359036
[TBL] [Abstract][Full Text] [Related]
12. Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.
Reidarson TH; Levy WE; Klostergaard J; Granger GA
J Natl Cancer Inst; 1982 Oct; 69(4):879-87. PubMed ID: 6956764
[TBL] [Abstract][Full Text] [Related]
13. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
14. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin.
Klostergaard J; Foster WA; Leroux ME
J Biol Response Mod; 1987 Jun; 6(3):313-30. PubMed ID: 3298554
[TBL] [Abstract][Full Text] [Related]
15. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.
Pabst MJ; Hedegaard HB; Johnston RB
J Immunol; 1982 Jan; 128(1):123-8. PubMed ID: 6274954
[TBL] [Abstract][Full Text] [Related]
16. Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages.
Brunda MJ; Sulich V; Wright RB; Palleroni AV
Int J Cancer; 1991 Jul; 48(5):704-8. PubMed ID: 1906430
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
Cameron DJ; Churchill WH
J Immunol; 1980 Feb; 124(2):708-12. PubMed ID: 7356710
[TBL] [Abstract][Full Text] [Related]
18. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
19. Human alveolar macrophages: wheat germ agglutinin-dependent tumor cell killing.
Ogawara M; Sone S; Ogura T
Jpn J Cancer Res; 1987 Mar; 78(3):288-95. PubMed ID: 3106285
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.
Taffet SM; Russell SW
J Immunol; 1981 Feb; 126(2):424-7. PubMed ID: 7451984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
